# Hypothesis: Nutrient Off-Loading and Ectopic Fat Reduction Reverse Insulin Resistance and Improve Cardiovascular Outcomes in Type 2 Diabetes—A Narrative Review

**Authors:** Joseph A. M. J. L. Janssen

PMC · DOI: 10.3390/ijms27052150 · International Journal of Molecular Sciences · 2026-02-25

## TL;DR

This review suggests that reducing excess nutrients and fat through treatments like bariatric surgery or specific drugs can reverse insulin resistance and improve heart health in type 2 diabetes.

## Contribution

The paper proposes a novel hypothesis linking nutrient off-loading and ectopic fat reduction to improved cardiovascular outcomes in type 2 diabetes.

## Key findings

- Bariatric surgery improves cardiovascular outcomes more than newer diabetes drugs.
- GLP-1 receptor agonists and SGLT2 inhibitors reduce glucose and normalize energy balance.
- Reducing ectopic fat is central to reversing insulin resistance and improving heart health.

## Abstract

Insulin resistance in type 2 diabetes is associated with cardiovascular disease. Nutritional overload, hyperinsulinemia, and physical inactivity are the major etiological factors driving the development of insulin resistance. In an obesogenic environment, insulin resistance has been proposed to protect the body against toxic fuel overload, hyperinsulinemia-induced injury, and metabolic stress. Insulin resistance has been further hypothesized to defend the heart and blood vessels against fuel overload when an individual is chronically overeating. Recent landmark cardiovascular outcome trials in type 2 diabetes show major improvements in cardiovascular disease outcomes after treatment with GLP-1 receptor agonists or SGLT2 inhibitors. Bariatric surgery achieves even greater improvements in cardiovascular disease outcomes than treatments with these newer pharmacological agents. It had been previously predicted that glucose-lowering approaches that normalize whole-body energy balance have the greatest potential to improve cardiovascular outcomes in type 2 diabetes. This review hypothesizes that treatment with bariatric surgery, GLP-1 receptor agonists, or SGLT2 inhibitors lowers glucose and nutritional off-loading, normalizes whole-body energy balance, and reduces ectopic fat depositions. This plays a central role in the dramatic reduction in cardiovascular disease and the reversal of insulin resistance in type 2 diabetes, which are observed after these three treatments.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** Type 2 Diabetes (MESH:D003924), Nutritional overload (MESH:D044342), hyperinsulinemia (MESH:D006946), Insulin Resistance (MESH:D007333), cardiovascular disease (MESH:D002318)
- **Chemicals:** glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984968/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984968/full.md

## References

182 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984968/full.md

---
Source: https://tomesphere.com/paper/PMC12984968